PROVIDER PROFILE · NPI 1972578185

Martha WadleighMD

Hematology-OncologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

199

Unique beneficiaries

—

Total services

422

Distinct HCPCS

Medicare payment

$29K

Peer benchmark

Total Medicare services vs. 360 Hematology-Oncology providers in MA — below median (cohort median 624).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$843K

Distinct drugs

Brand share

52.1%

Top prescribed drugs

Hydroxyurea23 claims

Ruxolitinib Phosphate20 claims

Momelotinib Dihydrochloride18 claims

Levofloxacin12 claims

QUALITY · MIPS · 2024

Final MIPS score

84.1

Quality

65.0

Cost

69.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.38%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Martha Wadleigh's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Scott Lovitch Pathology · Boston, MA	25	118
Olga Pozdnyakova Pathology · Philadelphia, PA	18	140
Sheng Xiao Pathology · Boston, MA	17	91
Elizabeth Morgan Pathology · Boston, MA	14	84
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	13	39
Olga Weinberg Pathology · Dallas, TX	12	70
Scott Rodig Pathology · Boston, MA	12	57
Ruben Carrasco Pathology · Boston, MA	11	40

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history